Solid Biosciences (SLDB) Shareholder's Equity Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.74% |
| Dec 31, 2025 | -5.26% |
| Sep 30, 2025 | 15.01% |
| Jun 30, 2025 | 16.77% |
| Mar 31, 2025 | 16.65% |
| Dec 31, 2024 | -12.97% |
| Sep 30, 2024 | -9.23% |
| Jun 30, 2024 | -6.70% |
| Mar 31, 2024 | -5.91% |
| Dec 31, 2023 | -1.43% |
| Sep 30, 2023 | 86.57% |
| Jun 30, 2023 | 59.02% |
| Mar 31, 2023 | 48.21% |
| Dec 31, 2022 | 38.28% |
| Sep 30, 2022 | 9.70% |
| Jun 30, 2022 | 28.48% |
| Mar 31, 2022 | 23.24% |
| Dec 31, 2021 | 18.48% |
| Sep 30, 2021 | 15.47% |
| Jun 30, 2021 | 13.60% |
| Mar 31, 2021 | 12.24% |
| Dec 31, 2020 | 61.71% |